Aethlon medical to present at the h.c. wainwright 25th annual global investment conference

San diego , aug. 30, 2023 /prnewswire/ -- aethlon medical, inc. (nasdaq: aemd), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that steven larosa, m.d., chief medical officer, and james frakes, chief financial officer, will present a company overview on tuesday, september 12 at 4:30 pm est, during the h.c.
AEMD Ratings Summary
AEMD Quant Ranking